Article Per Year (5 Year)
p-Index From 2020 - 2025
0.61
P-Index
This Author published in this journals
All Journal Eduvest - Journal of Universal Studies Proceedings Book of International Conference and Exhibition on The Indonesian Medical Education and Research Institute
Qomarasandhi, Johan
Unknown Affiliation
Aerospace Engineering Computer Science & IT Health Professions Medicine & Pharmacology Neuroscience Public Health Social Sciences

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Will-To-Live Scale as a Predictor of Depressive Symptoms in Elderly: an Evidence-Based Case Report Satryo, Eugene Alfathan; Qomarasandhi, Johan
Proceedings Book of International Conference and Exhibition on The Indonesian Medical Education Research Institute Vol. 7 No. - (2023): Proceedings Book of International Conference and Exhibition on The Indonesian M
Publisher : Writing Center IMERI FMUI

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69951/proceedingsbookoficeonimeri.v7i-.190

Abstract

An elderly man was admitted to inpatient care after a check-up with a gerontologist, stating that he had no will to continue living and showing other depressive symptoms. The gerontologist then ponders whether the will to live is prognostic for depression, specifically in elderly patients. The report aims to determine whether the will to live, measured by the Will-to-Live (WTL) scale, can predict depressive symptoms (DS) emerging in elderly patients. A literature search was conducted on three databases: PubMed, Cochrane, and EBSCOhost. Of the searches, two articles were selected for further critical appraisal using the criteria provided by the University of Oxford Centre of Evidence-Based Medicine. first study, using the WTL Scale to quantify WTL and the Geriatric Depression Scale (GDS) to measure DS, showed that WTL can predict DS but not vice versa with moderate negative correlation (r = -0.49 p<0.001). The second study analyzes the temporal relationship further, showing that WTL still has a negative correlation with DS (measured by modified GDS) (r=-0.4, p<0.05) when assessed in the same time frame but shows little to no correlation when used as a predictor for DS after a 1-year interval from the initial assessment (r= 0.14, p<0.05). The Will-To-Live Scale has the potential to be a more practical tool in predicting depressive symptoms in gerontology settings as compared to usual methods after further validation studies.
BCG Revaccination to Combat Tuberculosis Infection: an Evidence Based Case Report Rifa, Alissa; Qomarasandhi, Johan
Proceedings Book of International Conference and Exhibition on The Indonesian Medical Education Research Institute Vol. 7 No. - (2023): Proceedings Book of International Conference and Exhibition on The Indonesian M
Publisher : Writing Center IMERI FMUI

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69951/proceedingsbookoficeonimeri.v7i-.193

Abstract

An elderly man came to the Emergency Room with labored breathing with a history of prior tuberculosis infection and BCG vaccination when he was an infant. He was diagnosed with tuberculosis reinfection with negative microbiology result. This study aims to see whether revaccination of BCG vaccination will positively impact suppressing the rate of tuberculosis infection. A literature search was conducted on three databases: PubMed, Cochrane, and EBSCOhost. Of the searches, three articles were selected for further critical appraisal using the criteria provided by the University of Oxford Centre of Evidence-Based Medicine. The first study shows that BCG Revaccination does not become a protective factor against tuberculosis reinfection with OR 0.92 (0.80 – 1.05) in all populations yet interestingly yielded OR 0.77 (0.59-1.00) in HIV-negative patients, while the second study shows that BCG Revaccination can prevent conversion of QFT with the study showing p <0.05, thus believed to lower tuberculosis infection rates, the third study shows that BCG revaccination yield modest protection against TB infection after 15 years (Hazard Ratio 0.64 95% CI 0.46-0.89). The main difference between the studies is the main population, which the first study also includes HIV-positive patients. In conclusion, BCG Revaccination may be considered to be given and be considered as protective factor against tuberculosis reinfection in HIV-negative patients.
Co-Authors Rifa, Alissa Satryo, Eugene Alfathan